
Start-up profile
Nanomnia: Delivery science is becoming the deciding factor for next‑generation biologicals
As peptides, dsRNA and other fragile biological actives move closer to market, Italian nano‑biotech Nanomnia believes growth will increasingly come from developers who need delivery to be enabling, not incremental
















































